Cargando…
Priorities in reducing child mortality: Azithromycin and other interventions
In this Perspective, David Mabey and colleagues discuss a recent PLOS Medicine article on azithromycin as an intervention for reducing child mortality.
Autores principales: | Mabey, David, Okomo, Uduak, Greenwood, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491718/ https://www.ncbi.nlm.nih.gov/pubmed/32931499 http://dx.doi.org/10.1371/journal.pmed.1003364 |
Ejemplares similares
-
Continued development of azithromycin as a neuroprotective therapeutic for the treatment of spinal cord injury and other neurological conditions
por: Kopper, Timothy J., et al.
Publicado: (2020) -
Prioritizing Countries for Interventions to Reduce Child Mortality: Tools for Maximizing the Impact of Mass Drug Administration of Azithromycin
por: Matheson, Alastair I., et al.
Publicado: (2014) -
Mass Drug Administration of Azithromycin to Reduce Child Mortality: Only for High-Mortality Settings?
por: Tickell, Kirkby D., et al.
Publicado: (2020) -
Public health evolutionary biology of antimicrobial resistance: priorities for intervention
por: Baquero, Fernando, et al.
Publicado: (2015) -
Azithromycin Should Not Be Used to Treat COVID-19
por: Lighter, Jennifer, et al.
Publicado: (2020)